Input Needed for Next Phase of NIST Flow Cytometry Consortium Interlaboratory Studies; Comments Due October 31
The Standards Coordinating Body (SCB) is collecting data for the NIST Flow Cytometry Consortium and requests your input. The next phase of interlaboratory studies will focus on antigen-specific T Cells or CAR T cells, and your input is valuable to guide the direction of the studies. The SCB is reaching out to members of the regenerative medicine therapy community, including cellular therapy facilities, for input on needs and perceived gaps in flow cytometry methodologies. The goal is to perform studies that will be valuable to the stakeholders in this space.
The short, six-question survey can be found at https://www.surveymonkey.com/r/FC-TCell and responses are due by October 31, 2022. Questions can be directed to Katie Zander, Ph.D. at CZander@regenmedscb.org.